JP2023526567A5 - - Google Patents

Info

Publication number
JP2023526567A5
JP2023526567A5 JP2023513266A JP2023513266A JP2023526567A5 JP 2023526567 A5 JP2023526567 A5 JP 2023526567A5 JP 2023513266 A JP2023513266 A JP 2023513266A JP 2023513266 A JP2023513266 A JP 2023513266A JP 2023526567 A5 JP2023526567 A5 JP 2023526567A5
Authority
JP
Japan
Prior art keywords
patient
alkyl
alkoxy
hydrogen
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023513266A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526567A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031282 external-priority patent/WO2021231208A1/en
Publication of JP2023526567A publication Critical patent/JP2023526567A/ja
Publication of JP2023526567A5 publication Critical patent/JP2023526567A5/ja
Pending legal-status Critical Current

Links

JP2023513266A 2020-05-09 2021-05-07 バルドキソロンメチルまたはそのアナログを用いてｃｏｖｉｄ－１９を処置する方法 Pending JP2023526567A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063022479P 2020-05-09 2020-05-09
US63/022,479 2020-05-09
US202063053056P 2020-07-17 2020-07-17
US63/053,056 2020-07-17
PCT/US2021/031282 WO2021231208A1 (en) 2020-05-09 2021-05-07 Methods of treating covid-19 using bardoxolone methyl or analogs thereof

Publications (2)

Publication Number Publication Date
JP2023526567A JP2023526567A (ja) 2023-06-21
JP2023526567A5 true JP2023526567A5 (https=) 2024-05-16

Family

ID=76197607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513266A Pending JP2023526567A (ja) 2020-05-09 2021-05-07 バルドキソロンメチルまたはそのアナログを用いてｃｏｖｉｄ－１９を処置する方法

Country Status (10)

Country Link
US (1) US20230255982A1 (https=)
EP (1) EP4146226A1 (https=)
JP (1) JP2023526567A (https=)
KR (1) KR20230022164A (https=)
AU (1) AU2021273460A1 (https=)
BR (1) BR112022022599A2 (https=)
CA (1) CA3177913A1 (https=)
IL (1) IL298008A (https=)
MX (1) MX2022014034A (https=)
WO (1) WO2021231208A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3240963A1 (en) * 2021-12-23 2023-06-29 Steven Laplante Drug combinations for inhibiting coronavirus replication
WO2023170187A1 (en) * 2022-03-09 2023-09-14 Technische Universität München INHIBITION OF INTRACELLULAR PATHOGEN UPTAKE BY INHIBITORS OF THE IKK-α/NIK COMPLEX
CN116509874A (zh) * 2023-02-01 2023-08-01 潍坊医学院附属医院 甲基巴多索隆在制备改善病毒性心肌炎或病毒性心肌损伤的药物中的用途
CN118903154B (zh) * 2024-08-22 2025-11-11 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) 化合物CDDO-Im用于预防或治疗口蹄疫的新用途

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
CA2107894C (en) 1991-04-10 2003-10-14 Kenneth F. Buechler Crosstalk inhibitors and their uses
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
GB9212302D0 (en) 1992-06-10 1992-07-22 Applied Research Systems Method for improving measurement precision in evanescent wave optical biosensor assays
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6025395A (en) 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US7176237B2 (en) 2002-01-15 2007-02-13 The Trustees Of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
ES2401741T3 (es) 2007-05-08 2013-04-24 Abbott Laboratories Ensayo de péptido natriurético de tipo B humano que tiene una reducida reactividad cruzada con otras formas péptidicas
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
KR100905466B1 (ko) 2007-10-08 2009-07-02 한국과학기술원 차세대 셀룰라 통신시스템에서의 중계 통신방법
BRPI0907423A2 (pt) 2008-01-11 2020-10-27 Reata Pharmaceuticals, Inc. composto triterpenoide sintético para uso em um método de melhoria da função renal em um indivíduo, e uso do referido composto
WO2009146218A2 (en) 2008-04-18 2009-12-03 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
JP5529851B2 (ja) 2008-04-18 2014-06-25 リアタ ファーマシューティカルズ インコーポレイテッド 抗酸化炎症モジュレーター：ｃ−１７においてアミノ改変およびその他の改変を加えたオレアノール酸誘導体
KR101713140B1 (ko) 2008-04-18 2017-03-08 리타 파마슈티컬스 잉크. Ｃ-환에서 포화된 산화방지성 염증 조절제 올레아놀산 유도체
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
MX2010011439A (es) 2008-04-18 2011-01-25 Reata Pharmaceuticals Inc Moduladores de inflamacion antioxidantes: derivados del acido oleanolico homologacion c-17.
SI2395979T1 (sl) 2009-02-13 2017-12-29 Reata Pharmaceuticals, Inc. Peroralni farmacevtski sestavki, ki vsebujejo amorfni CDDO-Me, z zapoznelim sproščanjem
DK2558105T3 (da) * 2010-04-12 2020-01-27 Reata Pharmaceuticals Inc Bardoxolonmethyl til behandling af fedme
CN102875634B (zh) 2012-10-24 2014-08-20 苏州晶云药物科技有限公司 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
CN102887936A (zh) 2012-10-24 2013-01-23 苏州晶云药物科技有限公司 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯晶型
EP4736949A2 (en) * 2013-08-23 2026-05-06 Reata Pharmaceuticals Holdings, LLC Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
CN110198718B (zh) * 2016-11-08 2023-01-10 里亚塔医药控股有限责任公司 使用甲基巴多索隆或其类似物治疗阿尔波特综合征的方法
US11427533B2 (en) 2017-07-13 2022-08-30 Pliva Hrvatska D.O.O. Crystalline polymorphs of bardoxolone methyl
WO2021202547A1 (en) * 2020-04-01 2021-10-07 Triterpenoid Therapeutics, Inc. Methods and compositions for treating and preventing viral infection
WO2021202245A1 (en) * 2020-04-02 2021-10-07 Egaceutical Corporation Viral treatment regimens

Similar Documents

Publication Publication Date Title
JP2023526567A5 (https=)
JP5869469B2 (ja) 鉄が病因に関与する肝臓疾患の処置
JP2004522714A5 (https=)
US20120238591A1 (en) Acyclovir formulations
JP2011148806A (ja) 重症心不全の治療方法およびその薬剤
JP7617898B2 (ja) Ｅｙｐ００１を使用した改善された処置
EP3937944B1 (en) Toll-like receptor agonists for use in the treatment of hepatitis b
KR20220146496A (ko) 뉴클레오티드계 화합물의 코로나 바이러스 감염증의 치료에의 사용
JP2024507788A5 (https=)
JP2022533981A5 (https=)
JP2009513713A5 (https=)
CN112121044A (zh) 氨来占诺用于制备抗肝炎病毒药物的用途
JP6882205B2 (ja) 重度腎機能障害を有する癌患者に対する治療方法
Lithell et al. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study
CN113194945A (zh) 环吡酮的抑制hbv核心组装的用途
CN121443295A (zh) 治疗前列腺癌的方法
JP2002526441A (ja) 抗ウイルス性組合せ製剤
RU2104700C1 (ru) Способ лечения гепатита в
CN115105501A (zh) 西奥罗尼用于小细胞肺癌的治疗
US20190290673A1 (en) Compositions and methods for the treatment of hbv infection
JP3885135B2 (ja) Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤
WO2021161983A1 (en) Novel medicament for treating inflammatory disease
CN106619591B (zh) 奥昔卡因在制备药物中的用途及药物组合物
CN114515338B (zh) 一种用于治疗病毒性肝炎的药物组合物
JP4426654B2 (ja) 免疫調節用医薬組成物